<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Early ischemic <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) in the setting of an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e>) due to thrombotic <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> remains a major health problem </plain></SENT>
<SENT sid="1" pm="."><plain>Several animal studies have shown that platelet-dense granule contents released during <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation can induce <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesize that the platelet release reaction is involved in the predisposition to early ischemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A case-control study was performed in patients who survived <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> during a first <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> ("cases," n = 26) and in patients with one previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> without <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> ("controls," n = 24) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were on aspirin 100 mg OD </plain></SENT>
<SENT sid="5" pm="."><plain>Baseline platelet activation was assessed with flow cytometry </plain></SENT>
<SENT sid="6" pm="."><plain>Response to activation was assessed with aggregometry, flow cytometry and <z:chebi fb="95" ids="53371">PFA</z:chebi>-100 analysis </plain></SENT>
<SENT sid="7" pm="."><plain>Differences in platelet contents and content release were assessed by labeling platelet-dense granules with <z:chebi fb="2" ids="8711">mepacrine</z:chebi> and by measuring <z:chebi fb="19" ids="28790">serotonin</z:chebi> and <z:chebi fb="13" ids="16761">ADP</z:chebi>/ATP content </plain></SENT>
<SENT sid="8" pm="."><plain>Patient and <z:mpath ids='MPATH_124'>infarct</z:mpath> characteristics and baseline platelet function tests were similar between groups </plain></SENT>
<SENT sid="9" pm="."><plain>The mean time from event was 4.9 (±3.2) years among cases and 4.7 (±2.7) years among controls </plain></SENT>
<SENT sid="10" pm="."><plain>Dense granule release was similar in cases versus controls </plain></SENT>
<SENT sid="11" pm="."><plain>Platelet <z:chebi fb="19" ids="28790">serotonin</z:chebi> content in cases was higher than in controls (611 ± 118 ng/10E(9) platelets vs. 536 ± 141 ng/10(9), p = 0.048) </plain></SENT>
<SENT sid="12" pm="."><plain>Even years after the event, elevations in the platelet dense granule contents between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> survivors and controls may be detected </plain></SENT>
<SENT sid="13" pm="."><plain>These preliminary findings shed new light on the pathophysiological mechanisms underlying ischemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>, as platelet-dense granules may contain mediators of early ischemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> risk </plain></SENT>
</text></document>